630
Views
0
CrossRef citations to date
0
Altmetric
Review

Normothermic ex-vivo liver perfusion: where do we stand and where to reach?

ORCID Icon, &
Pages 1045-1058 | Received 04 Jun 2018, Accepted 24 Jul 2018, Published online: 20 Aug 2018

References

  • OPTN National Data. Organ Procurement Transplantation Network. United States; 2016.
  • Jassem W, Fuggle S, Thompson R, et al. Effect of ischemic preconditioning on the genomic response to reperfusion injury in deceased donor liver transplantation. Liver Transpl. 2009;15(12):1750–1765.
  • Amador A, Grande L, Martí J, et al. Ischemic pre-conditioning in deceased donor liver transplantation: a prospective randomized clinical trial. Am J Transplant. 2007;7(9):2180–2189.
  • Belzer FO, Southard JH. Principles of solid-organ preservation by cold storage. Transplantation. 1988;45(4):673–676.
  • Rauen U, Groot H D. New insights into the cellular and molecular mechanisms of cold storage injury. J Investig Med. 2004;52(5):299–309.
  • Feng XN, Xu X, Zheng S S. Current status and perspective of liver preservation solutions. Hepatobiliary Pancreat Dis Int. 2006;5(4):490–494.
  • Guibert EE, Petrenko AY, Balaban CL, et al. Organ preservation: current concepts and new strategies for the next decade. Transfus Med Hemotherapy. 2011;38(2):125–142.
  • Baskin-Bey ES, Washburn K, Feng S, et al. Clinical trial of the pan-caspase inhibitor, IDN-6556, in human liver preservation injury. Am J Transplant. 2007;7(1):218–225.
  • Busuttil RW, Lipshutz GS, Kupiec-Weglinski JW, et al. RPSGL-Ig for improvement of early liver allograft function: A double-blind, placebo-controlled, single-center phase II study. Am J Transplant. 2011;11(4):786–797.
  • Jamieson RW, Zilvetti M, Roy D, et al. Hepatic steatosis and normothermic perfusion—preliminary experiments in a porcine model. Transplantation. 2011;92(3):289–295.
  • Jayant K, Reccia I, Virdis FSAM. The role of normothermic perfusion in liver transplantation (TRaNsIT Study): a systematic review of preliminary studies. HPB Surg. 2018;2018:20186360423.
  • Hosgood SA. Renal transplantation after ex vivo normothermic perfusion: the first clinical study. Am J Transplant. 2013;13(5):1246–1252.
  • Brockmann J, Reddy S, Coussios C, et al. Normothermic perfusion: a new paradigm for organ preservation. Ann Surg. 2009;250(1):1–6.
  • Ali F, Dua A, Cronin DC. Changing paradigms in organ preservation and resuscitation. Curr Opin Organ Transplant. 2015;20(2):152–158.
  • Sutton ME, Op Den Dries S, Karimian N, et al. Criteria for viability assessment of discarded human donor livers during ex vivo normothermic machine perfusion. PLoS One. 2014;9(11):e110642.
  • Op Den Dries S, Karimian N, Sutton ME, et al. Ex vivo normothermic machine perfusion and viability testing of discarded human donor livers. Am J Transpl. 2013;13(5):1327–1335.
  • Yska MJ, Buis CI, Monbaliu D, et al. The role of bile salt toxicity in the pathogenesis of bile duct injury after non-heart-beating porcine liver transplantation. Transplantation. 2008;85(11):1625–1631.
  • Graham JA, Guarrera JV. ”Resuscitation” of marginal liver allografts for transplantation with machine perfusion technology. J Hepatol. 2014;61(2):418–431.
  • Mergental H, Roll GR. Normothermic machine perfusion of the liver. Clin Liver Dis. 2017;10:97–99.
  • Vogel T, Brockmann JG, Friend PJ. Ex-vivo normothermic liver perfusion: an update. Curr Opin Organ Transplant. 2010;15(2):167–172.
  • Ravikumar R, Jassem W, Mergental H, et al. Liver transplantation after ex vivo normothermic machine preservation: a phase 1 (first-in-man) clinical trial. Am J Transpl. 2016;16(6):1779–1787.
  • Jochmans I, Akhtar MZ, Nasralla D, et al. Past, present, and future of dynamic kidney and liver preservation and resuscitation. Am J Transplant. 2016;16(9):2545–2555.
  • Minor T, Efferz P, Fox M, et al. Controlled oxygenated rewarming of cold stored liver grafts by thermally graduated machine perfusion prior to reperfusion. Am J Transplant. 2013;13(6):1450–1460.
  • Ceresa CDL, Nasralla D, Coussios CC, et al. The case for normothermic machine perfusion in liver transplantation. Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc. 2018;24(2):269–275.
  • Bral M, Gala-Lopez B, Bigam D, et al. Preliminary single-center Canadian experience of human normothermic ex vivo liver perfusion. Results Clinical Trial Am J Transplant. 2017;17(4):1071–1080.
  • Selzner M, Goldaracena N, Echeverri J, et al. Normothermic ex vivo liver perfusion using steen solution as perfusate for human liver transplantation: first North American results. Liver Transpl. 2016;22(11):1501–1508.
  • Liu Q, Soliman B, Iuppa G, et al. First report of human liver transplantation after normothermic machine perfusion (NMP) in the United States. Am J Transpl. 2017;17(Suppl3).
  • Nasralla D, Coussios CC, Mergental H, et al. A randomized trial of normothermic preservation in liver transplantation. Nature. 2018;557(7703):50–56.
  • Nassar A, Liu Q, Farias K, et al. Ex vivo normothermic machine perfusion is safe, simple, and reliable: results from a large animal model. Surg Innov. 2015;22(1):61–69.
  • Watson CJE, Kosmoliaptsis V, Randle LV, et al. Normothermic perfusion in the assessment and preservation of declined livers before transplantation: hyperoxia and vasoplegia-important lessons from the first 12 cases. Transplantation. 2017;101(5):1084–1098.
  • Liu Q, Nassar A, Farias K, et al. Comparing normothermic machine perfusion preservation with different perfusates on porcine livers from donors after circulatory death. Am J Transplant. 2016;16(3):794–807.
  • Izamis ML, Tolboom H, Uygun B, et al. Resuscitation of ischemic donor livers with normothermic machine perfusion: a metabolic flux analysis of treatment in rats. PLoS One. 2013;8(7):e69758.
  • Schlegel A, Kron P, Graf R, et al. Warm vs cold perfusion techniques to rescue rodent liver grafts. J Hepatol. 2014;61(6):1267–1275.
  • Nui A, Katsuramaki T, Kikuchi H, et al. Successful ex vivo normothermic liver perfusion with purely artificial products using artificial blood. Int J Artif Organs. 2003;26(1):46–52.
  • Fontes P, Lopez R, Van Der Plaats A, et al. Liver preservation with machine perfusion and a newly developed cell-free oxygen carrier solution under subnormothermic conditions. Am J Transpl. 2015;15(2):381–394.
  • Laing RW, Mergental H, Yap C, et al. Viability testing and transplantation of marginal livers (VITTAL) using normothermic machine perfusion: study protocol for an open-label, non-randomised, prospective, single-arm trial. BMJ Open. 2017;7:e017733.
  • Kim HW, Greenburg AG. Artificial oxygen carriers as red blood cell substitutes: a selected review and current status. Artif Organs. 2004;28(9):813–828.
  • St. Peter SD, Imber CJ, Friend PJ. Liver and kidney preservation by perfusion. Lancet. 2002;359(9306):604–613.
  • Imber CJ, St Peter SD, Lopez De Cenarruzabeitia I, et al. Advantages of normothermic perfusion over cold storage in liver preservation. Transplantation. 2002;73(5):701–709.
  • Lee CY, Mangino MJ. Preservation methods for kidney and liver. Organogenesis. 2009;5(3):105–112.
  • Matton APM, Burlage LC, Van Rijn R, et al. Normothermic machine perfusion of donor livers without the need for human blood products. Liver Transpl. 2018;24(4):528–538.
  • Marecki H, Bozorgzadeh A, Porte R, et al. Liver ex-vivo machine perfusion preservation: a review of the methodology and results of large animal studies and clinical trials. Liver Transpl. 2017;23(5):679–695.
  • Eshmuminov D, Leoni F, Schneider MA, et al. Perfusion settings and additives in liver normothermic machine perfusion with red blood cells as oxygen carrier. A systematic review of human and porcine perfusion protocols. Transpl Int. 2018. doi: 10.1111/tri.13306. [ Epub ahead of print].
  • Mergental H, Perera MTPR, Laing RW, et al. Transplantation of declined liver allografts following normothermic ex-situ evaluation. Am J Transpl. 2016;16(11):3235–3245.
  • Reiling J, Lockwood DSR, Simpson AH, et al. Urea production during normothermic machine perfusion: price of success?. Liver Transpl. 2015;21(5):700–703.
  • He X, Guo Z, Zhao Q, et al. The first case of ischemia-free organ transplantation in humans: a proof of concept. Am J Transpl. 2018;18(3):737–744.
  • Liu Q, Nassar A, Buccini L, et al. Lipid metabolism and functional assessment of discarded human livers with steatosis undergoing 24 hours normothermic machine perfusion. Liver Transpl. 2017;24(2):233–245.
  • Goldaracena N, Echeverri J, Spetzler VN, et al. Anti-inflammatory signaling during ex vivo liver perfusion improves the preservation of pig liver grafts before transplantation. Liver Transpl. 2016;22(11):1573–1583.
  • Nassar A, Liu Q, Farias K, et al. Role of vasodilation during normothermic machine perfusion of DCD porcine livers. Int J Artif Organs. 2014;37(2):165–172.
  • Spoelstra-De Man AM, Smit B, Oudemans-Van Straaten HM, et al. Cardiovascular effects of hyperoxia during and after cardiac surgery. Anaesthesia. 2015;70(11):1307–1319.
  • Weigand K, Brost S, Steinebrunner N, et al. Ischemia/reperfusion injury in liver surgery and transplantation: pathophysiology. HPB Surg. 2012;2012:176723.
  • Zinchuk VV, Khodosovsky MN, Maslakov DA. Influence of different oxygen modes on the blood oxygen transport and prooxidant-antioxidant status during hepatic ischemia/reperfusion. Physiol Res. 2003;52(5):533–544.
  • Bral M, Gala-Lopez B, Thiesen A, et al. Determination of minimal hemoglobin level necessary for normothermic porcine ex situ liver perfusion. Transplantation. 2018. [ Epub ahead of print].
  • Jay CL, Skaro AI, Ladner DP, et al. Comparative effectiveness of donation after cardiac death versus donation after brain death liver transplantation: recognizing who can benefit. Liver Transpl. 2012;18(6):630–640.
  • Fondevila C, Hessheimer AJ, Flores E, et al. Applicability and results of Maastricht type 2 donation after cardiac death liver transplantation. Am J Transplant. 2012;12(1):162–170.
  • Xia W, Ke Q, Wang Y, et al. Donation after cardiac death liver transplantation: graft quality evaluation based on pretransplant liver biopsy. Liver Transpl. 2015;21(6):838–846.
  • Vairetti M, Ferrigno A, Rizzo V, et al. Subnormothermic machine perfusion protects against rat liver preservation injury: a comparative evaluation with conventional cold storage. Transplant Proc. 2007;39(6):1765–1767.
  • Ferrigno A, Rizzo V, Boncompagni E, et al. Machine perfusion at 20°C reduces preservation damage to livers from non-heart beating donors. Cryobiology. 2011;62(2):152–158.
  • Bessems M, Doorschodt BM, Kolkert JLP, et al. Preservation of steatotic livers: a comparison between cold storage and machine perfusion preservation. Liver Transpl. 2007;13(4):497–504.
  • Black SM, Whitson BA, Velayutham M. EPR spectroscopy as a predictive tool for the assessment of marginal donor livers perfused on a normothermic ex vivo perfusion circuit. Med Hypotheses. 2014;82(5):627–630.
  • Karangwa SA, Burlage LC, Adelmeijer J, et al. Activation of fibrinolysis, but not coagulation, during end-ischemic ex situ normothermic machine perfusion of human donor livers. Transplantation. 2017;101(2):e42–e48.
  • Watson CJE, Kosmoliaptsis V, Pley C, et al. Observations on the ex situ perfusion of livers for transplantation. Am J Transpl. 2018. doi: 10.1111/ajt.14687. [ Epub ahead of print].
  • Ayanoglu HO, Ulukaya S, Tokat Y. Causes of postreperfusion syndrome in living or cadaveric donor liver transplantations. Transplant Proc. 2003;35(4):1442–1444.
  • Fukazawa K, Yamada Y, Gologorsky E, et al. Hemodynamic recovery following postreperfusion syndrome in liver transplantation. J Cardiothorac Vasc Anesth. 2014;28(4):994–1002.
  • Bukowicka B, Akar RA, Olszewska A, et al. The occurrence of postreperfusion syndrome in orthotopic liver transplantation and its significance in terms of complications and short-term survival. Ann Transplant. 2011;16(2):26–30.
  • Chung IS, Kim HY, Shin YH, et al. Incidence and predictors of post-reperfusion syndrome in living donor liver transplantation. Clin Transplant. 2012;26(4):539–543.
  • Chui AKK, Shi L, Tanaka K, et al. Postreperfusion syndrome in orthotopic liver transplantation. Transplant Proc. 2000;32(7):2116–2117.
  • Siniscalchi A, Dante A, Spedicato S, et al. Hyperdynamic circulation in acute liver failure: reperfusion syndrome and outcome following liver transplantation. Transplant Proc. 2010;42(4):1197–1199.
  • Martell M, Coll M, Ezkurdia N, et al. Physiopathology of splanchnic vasodilation in portal hypertension. World J Hepatol. 2010;2(6):208–220.
  • Gracia-Sancho J, Maeso-Diaz R, Fernandez-Iglesias A, et al. New cellular and molecular targets for the treatment of portal hypertension. Hepatol Int. 2015;9(2):183–191.
  • Mahboub P, Bozorgzadeh A, Martins PN. Potential approaches to improve the outcomes of donation after cardiac death liver grafts. World J Transplant. 2016;6(2):314–320.
  • Angelico R, Perera MTPR, Ravikumar R, et al. Normothermic machine perfusion of deceased donor liver grafts is associated with improved postreperfusion hemodynamics. Transplant Direct. 2016;2(9):e97.
  • Russo L, Gracia-Sancho J, García-Calderó H, et al. Addition of simvastatin to cold storage solution prevents endothelial dysfunction in explanted rat livers. Hepatology. 2012;55(3):921–930.
  • Boehnert MU, Yeung JC, Bazerbachi F, et al. Normothermic acellular EX vivo liver perfusion reduces liver and bile duct injury of pig livers retrieved after cardiac death. Am J Transplant. 2013;13(6):1441–1449.
  • Le Dinh H, De Roover A, Kaba A, et al. Donation after cardio-circulatory death liver transplantation. World J Gastroenterol. 2012;18(33):4491–4506.
  • Pareja E, Cortes M, Navarro R, et al. Vascular complications after orthotopic liver transplantation. Transplant Proc. 2010;42(8):2970–2972.
  • Selton J, Schlegal A, De Jonge J, et al. Hypo- and normothermic perfusion of the liver: which way to go?. Best Pract Res Clin Gastroenterol. 2017;31(2):171–179.
  • Tang JX, Na N, Li JJ, et al. Outcomes of controlled donation after cardiac death compared with donation after brain death in liver transplantation: a systematic review and meta-analysis. Transplant Proc. 2018;50(1):33–41.
  • Olthoff KM, Kulik L, Samstein B, et al. Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors. Liver Transpl. 2010;16(8):943–949.
  • Croome KP, Wall W, Quan D, et al. Evaluation of the updated definition of early allograft dysfunction in donation after brain death and donation after cardiac death liver allografts. Hepatobiliary Pancreat Dis Int. 2012;11(4):372–376.
  • Nasralla D, Ploeg R, Coussios CFP,, . Outcomes from a multinational randomised controlled trial comparing normothermic machine perfusion with static cold storage in human liver transplantation. Am J Transpl. 2017;(Suppl 3).
  • Jay CL, Lyuksemburg V, Ladner DP, et al. Ischemic cholangiopathy after controlled donation after cardiac death liver transplantation. Ann Surg. 2011;253(2):259–264.
  • Op Den Dries S, Me S, Lisman T, et al. Protection of bile ducts in liver transplantation: looking beyond ischemia. Transplantation. 2011;92(4):373–379.
  • Op Den Dries S, Westerkamp AC, Karimian N, et al. Injury to peribiliary glands and vascular plexus before liver transplantation predicts formation of non-anastomotic biliary strictures. J Hepatol. 2014;60(6):1172–1179.
  • Op Den Dries S, Karimian N, Westerkamp AC, et al. Normothermic machine perfusion reduces bile duct injury and improves biliary epithelial function in rat donor livers. Liver Transpl. 2016;22(7):994–1005.
  • Liu Q, Nassar A, Farias K, et al. Sanguineous normothermic machine perfusion improves hemodynamics and biliary epithelial regeneration in donation after cardiac death porcine livers. Liver Transpl. 2014;20(8):987–999.
  • Shapiro AMJ. Normothermic machine perfusion: a new world deserving careful exploration. Am J Transplant. 2017;17(7): 1958. Response to.
  • Parsons RF, Guarrera JV. Preservation solutions for static cold storage of abdominal allografts. Curr Opin Organ Transplant. 2014;19(2):100–107.
  • Vogel T, Brockmann JG, Pigott D, et al. Successful transplantation of porcine liver grafts following 48-hour normothermic preservation. PLoS One. 2017;12(11):e0188494.
  • Nebrig M, Neuhaus P, Pascher A. Advances in the management of the explanted donor liver. Nat Rev Gastroenterol Hepatol. 2014;11(8):489–496.
  • Organ Donation and Transplantation Activity Report. NHS Blood Transpl. 2016/17. p. 2017.
  • Andrews PA, Burnapp L, Manas D. Summary of the british transplantation society guidelines for transplantation from donors after deceased circulatory death. Transplantation. 2014;97(3):265–270.
  • Fondevila C, Hessheimer AJ, Maathuis M-HJ, et al. Superior preservation of DCD livers with continuous normothermic perfusion. Ann Surg. 2011;254(6):1000–1007.
  • Reccia I, Kumar J, Akladios C, et al. Non-alcoholic fatty liver disease: a sign of systemic disease. Metabolism. 2017;72:94–108.
  • Al S, Ob L, Aas D, et al. The biopsied donor liver: incorporating macrosteatosis into high-risk donor assessment. Liver Transpl. 2010;16(7):874–884.
  • Angele MK, Rentsch M, Hartl WH, et al. Effect of graft steatosis on liver function and organ survival after liver transplantation. Am J Surg. 2008;195(2):214–220.
  • Perez-Daga JA, Santoyo J, Suarez MA, et al. Influence of degree of hepatic steatosis on graft function and postoperative complications of liver transplantation. Transpl Proc. 2006;38(8):2468–2470.
  • Li J, Liu B, Yan LN, et al. Reversal of graft steatosis after liver transplantation: prospective study. Transplant Proc. 2009;41(9):3560–3563.
  • Westerkamp AC, De Boer MT, Van Den Berg AP, et al. Similar outcome after transplantation of moderate macrovesicular steatotic and nonsteatotic livers when the cold ischemia time is kept very short. Transpl Int. 2015;28(3):319–329.
  • Okamura Y, Hata K, Tanaka H, et al. Impact of subnormothermic machine perfusion preservation in severely steatotic rat livers: a detailed assessment in an isolated setting. Am J Transplant. 2017;17(5):1204–1215.
  • Nagrath D, Xu H, Tanimura Y, et al. Metabolic preconditioning of donor organs: defatting fatty livers by normothermic perfusion ex vivo. Metab Eng. 2009;11(4–5):274–283.
  • Banan B, Watson R, Xu M, et al. Development of a normothermic extracorporeal liver perfusion system toward improving viability and function of human extended criteria donor livers. Liver Transpl. 2016;22(7):979–993.
  • Hu J, Wang Z, Tan C-J, et al. Plasma microRNA, a potential biomarker for acute rejection after liver transplantation. Transplantation. 2013;95(8):991–999.
  • Germani G, Rodriguez-Castro K, Russo FP, et al. Markers of acute rejection and graft acceptance in liver transplantation. World J Gastroenterol. 2015;21(4):1061–1068.
  • Schmuck RB, Reutzel-Selke A, Raschzok N, et al. Bile: miRNA pattern and protein-based biomarkers may predict acute cellular rejection after liver transplantation. Biomarkers. 2017;22(1):19–27.
  • Farid WR, Pan Q, Van Der Meer AJP, et al. Hepatocyte-derived microRNAs as serum biomarkers of hepatic injury and rejection after liver transplantation. Liver Transpl. 2012;18(3):290–297.
  • Andaloussi S EL, Mager I, Breakefield XO, et al. Extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov. 2013;12(5):347–357.
  • Blanco E, Shen H, Ferrari M. Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat Biotechnol. 2015;33(9):941–951.
  • Raposo G, Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol. 2013;200(4):373–383.
  • Camussi G, Quesenberry PJ. Perspective of the potential therapeutic uses of vesicles. Exosomes Microvesicles. 2013;1:6.
  • Herrera MB, Fonsato V, Bruno S, et al. Human liver stem cells improve liver injury in a model of fulminant liver failure. Hepatology. 2013;57(1):311–319.
  • Navarro-Tableros V, Herrera Sanchez MB, FIGliolini F, et al. Recellularization of rat liver scaffolds by human liver stem cells. Tissue Eng. 2015;21(11–12):1929–1939.
  • Nojima H, Freeman CM, Schuster RM, et al. Hepatocyte exosomes mediate liver repair and regeneration via sphingosine-1-phosphate. J Hepatol. 2016;64(1):60–68.
  • Masyuk AI, Huang BQ, Ward CJ, et al. Biliary exosomes influence cholangiocyte regulatory mechanisms and proliferation through interaction with primary cilia. Am J Physiol Gastrointest Liver Physiol. 2010;299(4):G990–999.
  • Herrera MB, Bruno S, Buttiglieri S, et al. Isolation and characterization of a stem cell population from adult human liver. Stem Cells. 2006;24(12):2840–2850.
  • Herrera MB, Fonsato V, Gatti S, et al. Human liver stem cell-derived microvesicles accelerate hepatic regeneration in hepatectomized rats. J Cell Mol Med. 2010;14(6B):1605–1618.
  • Gravante G, Ong SL, Metcalfe MS, et al. Effects of hypoxia due to isovolemic hemodilution on an ex vivo normothermic perfused liver model. J Surg Res. 2010;160(1):73–80.
  • Fonsato V, Collino F, Herrera MB, et al. Human liver stem cell-derived microvesicles inhibit hepatoma growth in SCID mice by delivering antitumor microRNAs. Stem Cells. 2012;30(9):1985–1998.
  • Akyurekli C, Le Y, Richardson RB, et al. A systematic review of preclinical studies on the therapeutic potential of mesenchymal stromal cell-derived microvesicles. Stem Cell Rev Reports. 2015;11(1):150–160.
  • Biancone L, Bruno S, Deregibus MC, et al. Therapeutic potential of mesenchymal stem cell-derived microvesicles. Nephrol Dial Transplant. 2012;27(8):3037–3042.
  • Rigo F, De Stefano N, Navarro-Tableros V, et al. Extracellular vesicles from human liver stem cells reduce injury in an ex vivo normothermic hypoxic rat liver perfusion model. Transplantation. 2018;102(5):e205–210.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.